Quantbot Technologies’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$849K Buy
8,818
+1,425
+19% +$143K 0.03% 652
2025
Q4
$719K Buy
7,393
+5,084
+220% +$436K 0.02% 791
2025
Q3
$164K Buy
+2,309
New +$154K ﹤0.01% 1349
2025
Q2
Sell
-1,486
Closed -$78K 1776
2025
Q1
$78K Buy
+1,486
New +$83.5K ﹤0.01% 1272
2024
Q4
Sell
-2,320
Closed -$117K 1651
2024
Q3
$117K Buy
2,320
+1,052
+83% +$48.5K ﹤0.01% 1150
2024
Q2
$55.7K Sell
1,268
-530
-29% -$22.5K ﹤0.01% 1231
2024
Q1
$79.1K Buy
1,798
+454
+34% +$20.1K ﹤0.01% 1251
2023
Q4
$63.8K Buy
1,344
+137
+11% +$5.76K ﹤0.01% 1291
2023
Q3
$53.6K Buy
1,207
+94
+8% +$4.37K ﹤0.01% 1235
2023
Q2
$53.1K Buy
+1,113
New +$50.2K ﹤0.01% 1307
2022
Q2
Sell
-2,639
Closed -$118K 1903
2022
Q1
$118K Buy
+2,639
New +$122K 0.01% 999

Other funds holding IRMD

Quantbot Technologies's IRMD Position: Q1 2026 in Review

Quantbot Technologies increased its iRadimed (IRMD) stake by 19% in Q1 2026, buying an estimated $143K and bringing the position to 8,818 shares worth $849K. The position accounts for 0.03% of the portfolio, ranked #652.

Quantbot Technologies first reported a position in IRMD in Q1 2022 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Quantbot Technologies held 8,818 shares of iRadimed worth $849K as of Q1 2026.
  • Quantbot Technologies bought 1,425 iRadimed shares in Q1 2026, an estimated $143K.
  • iRadimed made up 0.03% of Quantbot Technologies's portfolio in Q1 2026, its #652 holding.
  • Quantbot Technologies first reported a position in iRadimed in Q1 2022 and has held it in 11 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.